Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review

• Published in: Foods Vol. 13; no. 18; p. 2886
• Main Authors: Cruz Neto, José Patrocínio Ribeiro, de Luna Freire, Micaelle Oliveira, de Albuquerque Lemos, Deborah Emanuelle, Ribeiro Alves, Rayanne Maira Felix, de Farias Cardoso, Emmily Ferreira, de Moura Balarini, Camille, Duman, Hatice, Karav, Sercan, de Souza, Evandro Leite, de Brito Alves, José Luiz
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.09.2024; MDPI
• Subjects: Arteriosclerosis; Atherogenesis; Atherosclerosis; Bacteria; Bile acids; Blood circulation disorders; Cell adhesion & migration; Cytokines; Diabetes; Disease; Drug therapy; Dysbacteriosis; Endothelium; Fatty acids; Fermentation; Functional foods; Functional foods & nutraceuticals; gut microbiota; Health promotion; Homeostasis; Hypertension; Immune system; Inflammation; Intestinal microflora; Lipid metabolism; Lipids; Metabolic disorders; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Modulation; nutraceuticals; Oxidative metabolism; Oxidative stress; Phenols; Physiological aspects; probiotic; Probiotics; Quercetin; Resveratrol; Review; Reviews; Taxonomy; Thrombosis; Type 2 diabetes; Vascular diseases; atherosclerosis; quercetin; probiotic; resveratrol; nutraceuticals; gut microbiota

Atherosclerosis (AS) is a chronic inflammatory vascular disease. Dysregulated lipid metabolism, oxidative stress, and inflammation are the major mechanisms implicated in the development of AS. In addition, evidence suggests that gut dysbiosis plays an important role in atherogenesis, and modulation...